<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33960434</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>13</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1749-6632</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>1500</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Annals of the New York Academy of Sciences</Title>
          <ISOAbbreviation>Ann N Y Acad Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Antitumor and antimigration effects of Salvia clandestina L. extract on osteosarcoma cells.</ArticleTitle>
        <Pagination>
          <StartPage>34</StartPage>
          <EndPage>47</EndPage>
          <MedlinePgn>34-47</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1111/nyas.14601</ELocationID>
        <Abstract>
          <AbstractText>Salvia clandestina L. is a wild perennial species present in the Salento area of Italy. Here, we examined the in vitro effects of an aqueous extract of S. clandestina L. on the MG-63 osteosarcoma cell line. The extract reduced osteosarcoma cell viability mainly by way of apoptosis, as we observed (1) upregulation of gene and protein expression of p53, cyclin-dependent kinase inhibitors p21<sup>WAF1</sup> and p27<sup>Kip1</sup> , and proapoptotic BAX; (2) activation of caspases; and (3) induction of a sub-G<sub>1</sub> peak in the cell cycle. The mitogen-activated protein kinases (MAPKs) JNK1/2 and p38 are activated and involved in the intracellular effects of the S. clandestina extract, as preincubation with the JNK1/2 inhibitor SP600125 or the p38 inhibitor SB203580 significantly decreased S. clandestina extract-induced cytotoxicity and inhibited increase in p53, p21<sup>WAF1</sup> , p27<sup>Kip1</sup> , and BAX. SP600125 also inhibited mRNA levels for all the aforementioned proteins, while SB203580 only affected p53 mRNA. Furthermore, S. clandestina extract treatment counteracted epithelial-to-mesenchymal transition, inhibited cell migration, and decreased the expression and activity of matrix metalloproteinase MMP2. In addition, S. clandestina extract enhanced the cytotoxic activity of cisplatin on MG-63 cells through downregulation of the Akt/PKB protein kinase. We conclude that S. clandestina extract may be a novel agent for osteosarcoma treatment.</AbstractText>
          <CopyrightInformation>© 2021 The Authors. Annals of the New York Academy of Sciences published by Wiley Periodicals LLC on behalf of New York Academy of Sciences.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Muscella</LastName>
            <ForeName>Antonella</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0002-2822-9929</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological and Environmental Science and Technologies (DiSTeBA), University of Salento, Lecce, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Stefàno</LastName>
            <ForeName>Erika</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biological and Environmental Science and Technologies (DiSTeBA), University of Salento, Lecce, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>De Bellis</LastName>
            <ForeName>Luigi</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0002-6047-3526</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological and Environmental Science and Technologies (DiSTeBA), University of Salento, Lecce, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Nutricati</LastName>
            <ForeName>Eliana</ForeName>
            <Initials>E</Initials>
            <Identifier Source="ORCID">0000-0002-1197-5693</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological and Environmental Science and Technologies (DiSTeBA), University of Salento, Lecce, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Negro</LastName>
            <ForeName>Carmine</ForeName>
            <Initials>C</Initials>
            <Identifier Source="ORCID">0000-0001-6981-2216</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological and Environmental Science and Technologies (DiSTeBA), University of Salento, Lecce, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Marsigliante</LastName>
            <ForeName>Santo</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0001-6535-3286</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Biological and Environmental Science and Technologies (DiSTeBA), University of Salento, Lecce, Italy.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>05</Month>
          <Day>07</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Ann N Y Acad Sci</MedlineTA>
        <NlmUniqueID>7506858</NlmUniqueID>
        <ISSNLinking>0077-8923</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000972">Antineoplastic Agents, Phytogenic</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.24.-</RegistryNumber>
          <NameOfSubstance UI="D020782">Matrix Metalloproteinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000972" MajorTopicYN="N">Antineoplastic Agents, Phytogenic</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001859" MajorTopicYN="N">Bone Neoplasms</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D049109" MajorTopicYN="N">Cell Proliferation</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058750" MajorTopicYN="N">Epithelial-Mesenchymal Transition</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020782" MajorTopicYN="N">Matrix Metalloproteinases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012516" MajorTopicYN="N">Osteosarcoma</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D027544" MajorTopicYN="N">Salvia</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019032" MajorTopicYN="N">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">MAPKs</Keyword>
        <Keyword MajorTopicYN="Y">MG-63 osteosarcoma</Keyword>
        <Keyword MajorTopicYN="Y">MMPs</Keyword>
        <Keyword MajorTopicYN="Y">Salvia clandestina L.</Keyword>
        <Keyword MajorTopicYN="Y">apoptosis</Keyword>
        <Keyword MajorTopicYN="Y">danshensu</Keyword>
        <Keyword MajorTopicYN="Y">epithelial-to-mesenchymal transition</Keyword>
        <Keyword MajorTopicYN="Y">phenolic compounds</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>2</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>3</Month>
          <Day>23</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>8</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>9</Hour>
          <Minute>7</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33960434</ArticleId>
        <ArticleId IdType="pmc">PMC8518948</ArticleId>
        <ArticleId IdType="doi">10.1111/nyas.14601</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>

Lee, J.S.
, DuBois S.G., Boscardin W.J., et al. 2014. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma. Cancer
120: 3987–3993.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25116228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Longhi, A.
, Errani C., De Paolis M., et al. 2006. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat. Rev.
32: 423–436.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16860938</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Wesolowski, R.
 &amp; Budd G.T.. 2010. Use of chemotherapy for patients with bone and soft‐tissue sarcomas. Cleve. Clin. J. Med.
77: S23–S26.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20179184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kager, L.
, Tamamyan G. &amp; Bielack S.. 2017. Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncol. 13: 357.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">27651036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Bjørnland, K.
, Flatmark K., Pettersen S., et al. 2005. Matrix metalloproteinases participate in osteosarcoma invasion. J. Surg. Res.
127: 151–156.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16083752</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Zhang, M.
 &amp; Zhang X.. 2015. Association of MMP‐2 expression and prognosis in osteosarcoma patients. Int. J. Clin. Exp. Pathol.
8: 14965–14970.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4713615</ArticleId>
            <ArticleId IdType="pubmed">26823829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Schirrmacher, V.

2019. From chemotherapy to biological therapy: a review of novel concepts to reduce the side effects of systemic cancer treatment (Review). Int. J. Oncol.
54: 407–419.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6317661</ArticleId>
            <ArticleId IdType="pubmed">30570109</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Soldati, L.
, Di Renzo L., Jirillo E., et al. 2018. The influence of diet on anti‐cancer immune responsiveness. J. Transl. Med.
16: 75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5859494</ArticleId>
            <ArticleId IdType="pubmed">29558948</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Spencer, J.P.
, Abd El Mohsen M.M., Minihane A.M., et al. 2008. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research. Br. J. Nutr.
99: 12–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17666146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Del Bo, C.
, Bernardi S., Marino M., et al. 2019. Systematic review on polyphenol intake and health outcomes: is there sufficient evidence to define a health‐promoting polyphenol‐rich dietary pattern?
Nutrients
11: 1355.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6627994</ArticleId>
            <ArticleId IdType="pubmed">31208133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Nicolì, F.
, Vergine M., Negro C., et al. 2019.. 

Salvia clandestina L.: unexploited source of danshensu. Nat. Prod. Res.
33: 439–442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29553808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Zhou, X.
, Chan S.W., Tseng H.L., et al. 2012.. 
Danshensu is the major marker for the antioxidant and vasorelaxation effects of Danshen (Salvia miltiorrhiza) water‐extracts produced by different heat water‐extractions. Phytomedicine
19: 1263–1269.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23026310</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Fu, L.
, Han B., Zhou Y., et al. 2020. The anticancer properties of tanshinones and the pharmacological effects of their active ingredients. Front. Pharmacol.
11: 193.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7098175</ArticleId>
            <ArticleId IdType="pubmed">32265690</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Makkar, H.P.S.
, Blummel M., Borowy N.K. &amp; Becker K.. 1993. Gravimetric determination of tannins and their correlations with chemical and protein precipitation methods. J. Sci. Food Agric.
61: 161–165.</Citation>
        </Reference>
        <Reference>
          <Citation>

Muscella, A.
, Vetrugno C., Antonaci G., et al. 2015. PKC‐δ/PKC‐α activity balance regulates the lethal effects of cisplatin. Biochem. Pharmacol.
98: 29–40.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26300055</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Muscella, A.
, Vetrugno C., Cossa L.G. &amp; Marsigliante S.. 2020. TGF‐β1 activates RSC96 Schwann cells migration and invasion through MMP‐2 and MMP‐9 activities. J. Neurochem.
153: 525–538.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31729763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Sarker, H.
, Hardy E., Haimour A., et al. 2019. Identification of fibrinogen as a natural inhibitor of MMP‐2. Sci. Rep.
9: 4340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6416301</ArticleId>
            <ArticleId IdType="pubmed">30867536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Harrison, D.J.
 &amp; Schwartz C.L.. 2017. Osteogenic sarcoma: systemic chemotherapy options for localized disease. Curr. Treat. Options Oncol.
18: 24.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28391422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Oun, R.
, Moussa Y.E. &amp; Wheate N.J.. 2018. The side effects of platinum‐based chemotherapy drugs: a review for chemists. Dalton Trans. 47: 6645–6653.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29632935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Thangaraj, K.
, Balasubramanian B., Park S., et al. 2019. Orientin induces G0/G1 cell cycle arrest and mitochondria mediated intrinsic apoptosis in human colorectal carcinoma HT29 cells. Biomolecules
9: 418.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6770649</ArticleId>
            <ArticleId IdType="pubmed">31461995</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Beckerman, R.
 &amp; Prives C.. 2010. Transcriptional regulation by P53. Cold Spring Harb. Perspect. Biol.
2: a000935.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2908772</ArticleId>
            <ArticleId IdType="pubmed">20679336</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Haigis, K.M.
 &amp; Sweet‐Cordero A.. 2001. New insights into oncogenic stress. Nat. Genet.
43: 177–178.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21350495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Sui, X.
, Kong N., Ye L., et al. 2014. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett.
344: 174–179.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24333738</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Saha, M.N.
, Jiang H., Yang Y., et al. 2012. Targeting p53 via JNK pathway: a novel role of RITA for apoptotic signaling in multiple myeloma. PLoS One
7: e30215.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3262803</ArticleId>
            <ArticleId IdType="pubmed">22276160</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ashcroft, M.
, Kubbutat M.H. &amp; Vousden K.H.. 1999. Regulation of p53 function and stability by phosphorylation. Mol. Cell. Biol.
19: 1751–1758.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC83968</ArticleId>
            <ArticleId IdType="pubmed">10022862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Bulavin, D.V.
, Saito S., Hollander M.C., et al. 1999. Phosphorylation of human p53 by p38 kinase coordinates N‐terminal phosphorylation and apoptosis in response to UV radiation. EMBO J.
18: 6845–6854.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1171747</ArticleId>
            <ArticleId IdType="pubmed">10581258</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Youn, M.J.
, So H.S., Cho H.J., et al. 2008. Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase mediated pathway in HeLa cells. Biol. Pharm. Bull.
31: 789–795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18451495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Zhang, J.
, Yu X.H., Yan Y.G., et al. 2015. PI3K/Akt signaling in osteosarcoma. Clin. Chim. Acta
444: 182–192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25704303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Liu, B.
, Yan S., Qu L. &amp; Zhu J.. 2017. Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. Cancer Cell Int.
17: 1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5209942</ArticleId>
            <ArticleId IdType="pubmed">28053596</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Yang, F.
, Lv L.Z., Cai Q.C. &amp; Jiang Y.. 2015. Potential roles of EZH2, Bmi‐1 and miR‐203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B. World J. Gastroenterol.
21: 13268–13276.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4679758</ArticleId>
            <ArticleId IdType="pubmed">26715809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Zhang, Y.
, Wei R‐X., Zhu X‐B., et al. 2012. Tanshinone IIA induces apoptosis and inhibits the proliferation, migration, and invasion of the osteosarcoma MG‐63 cell line in vitro
. Anticancer Drugs
23: 212–219.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22126901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Xie, Z.
, He B., Jiang Z. &amp; Zhao L.. 2020. Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK‐Nrf2 signaling pathway. J. Recept. Signal. Transduct. Res.
40: 591–598.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32496906</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Jin, J.
, Cai L., Liu Z.M. &amp; Zhou X.S.. 2013. miRNA‐218 inhibits osteosarcoma cell migration and invasion by down‐regulating of TIAM1, MMP2 and MMP9. Asian Pac. J. Cancer Prev.
14: 3681–3684.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23886165</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Kalluri, R.
 &amp; Weinberg R.A.. 2009. The basics of epithelial‐mesenchymal transition. J. Clin. Invest.
119: 1420–1428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2689101</ArticleId>
            <ArticleId IdType="pubmed">19487818</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Yang, G.
, Yuan J. &amp; Li K.. 2013. EMT transcription factors: implication in osteosarcoma. Med. Oncol.
30: 697.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23975634</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>

Ghorbani, A.
 &amp; Esmaeilizadeh M.. 2017. Pharmacological properties of Salvia officinalis and its components. J. Tradit. Complement. Med. 7: 433–440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5634728</ArticleId>
            <ArticleId IdType="pubmed">29034191</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
